pharma · Osteoarthritis · Osteoporosis
Nordic Bioscience
Nordic Bioscience A/S
Nordic Bioscience A/S is a pharma organization headquartered in Herlev, DK. Primary therapeutic focus areas include Osteoarthritis, Osteoporosis, Ovarian cancer, Advanced prostate cancer, Atopic dermatitis. NovaPharmaNew
Herlev, DK HQ
1991 Founded
228 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Herlev, DK
- Founded
- 1991
- Employees
- 228
- Programs
- 5
- Drugs
- 10
- Patents
- 0
CSCI-SKT-B1001
Phase 2 · small molecule · Atopic dermatitis
CSCI-SKT-B1001 for Atopic dermatitis is a Phase 2 program (small_molecule) at Nordic Bioscience A/S with 1 ClinicalTrials.gov record(s).
Internal code CSCI-SKT-B1001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Nordic Bioscience A/S
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Atopic dermatitis
- Status
- active
- Trials
- 1